Related Experiment Video
Updated: Mar 31, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
NMDA receptor encephalitis with cancer of unknown primary origin
Arzu Çoban1, Gökçen Gündoğdu2, Mürüvvet Poyraz3
1Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul - Turkey.
Purpose:
N-methyl-D-aspartate receptor (NMDAR) encephalitis may present as a paraneoplastic syndrome in young women and is often associated with ovarian teratoma.
Methods:
We report 2 male cases of NMDAR encephalitis presenting with metastatic cancer of unknown primary origin.
Results:
Both patients showed cognitive dysfunction as well as other neurological symptoms, slow waves on EEG, and NMDAR antibodies in sera and CSF. Symptoms were effectively treated by pulse steroid and intravenous immunoglobulin treatment. The patients developed metastatic small cell neuroendocrine carcinoma of the parotid gland and inguinal metastatic squamous cell cancer shortly after their neurological episodes. Follow-up PET studies showed small cell lung cancer in the first patient while no primary origin could be found in the second patient.
Conlusions:
Our cases imply that NMDAR encephalitis may present with metastatic cancers that display slow progression rates and occur after encephalitis attacks.
Insights
N-methyl-D-aspartate receptor (NMDAR) encephalitis, typically seen in women, can also affect men with metastatic cancer. These cases highlight a potential link between NMDAR encephalitis and slow-progressing cancers.
Area of Science:
- Neurology
- Oncology
Background:
- N-methyl-D-aspartate receptor (NMDAR) encephalitis is often a paraneoplastic syndrome in young women, frequently linked to ovarian teratoma.
- This condition involves autoimmune attacks on NMDARs, leading to severe neurological and psychiatric symptoms.
Observation:
- Two male patients presented with NMDAR encephalitis and metastatic cancer of unknown primary origin.
- Both patients exhibited cognitive dysfunction, neurological symptoms, EEG abnormalities, and NMDAR antibodies in serum and cerebrospinal fluid.
- Treatment with pulse steroids and intravenous immunoglobulin was effective for their neurological symptoms.
Findings:
- Following neurological recovery, patients developed metastatic small cell neuroendocrine carcinoma of the parotid gland and inguinal metastatic squamous cell cancer.
- Further investigations revealed small cell lung cancer in one patient; the primary origin remained unidentified in the other.
- These cancers demonstrated slow progression rates.
Implications:
- NMDAR encephalitis can be associated with metastatic cancers in male patients, not exclusively young women.
- The findings suggest that NMDAR encephalitis may precede the clinical manifestation of certain slow-progressing metastatic cancers.
- This association warrants further investigation into the paraneoplastic potential of NMDAR encephalitis across diverse patient populations and cancer types.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Arboviral Encephalitis